ID   ESR2_RAT                Reviewed;         530 AA.
AC   Q62986; O35784; O35785; O55015; O55016; O70195; Q9R185;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   02-OCT-2024, entry version 204.
DE   RecName: Full=Estrogen receptor beta;
DE            Short=ER-beta;
DE   AltName: Full=Nuclear receptor subfamily 3 group A member 2;
GN   Name=Esr2; Synonyms=Erbeta, Nr3a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-530 (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Prostate;
RX   PubMed=8650195; DOI=10.1073/pnas.93.12.5925;
RA   Kuiper G.G.J.M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A.;
RT   "Cloning of a novel receptor expressed in rat prostate and ovary.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5925-5930(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-530 (ISOFORM 2), FUNCTION (ISOFORMS 1 AND
RP   2), AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Ovary;
RX   PubMed=9600083; DOI=10.1006/bbrc.1998.8590;
RA   Maruyama K., Endoh H., Sasaki-Iwaoka H., Kanou H., Shimaya E.,
RA   Hashimoto S., Kato S., Kawashima H.;
RT   "A novel isoform of rat estrogen receptor beta with 18 amino acid insertion
RT   in the ligand binding domain as a putative dominant negative regular of
RT   estrogen action.";
RL   Biochem. Biophys. Res. Commun. 246:142-147(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RC   STRAIN=Wistar; TISSUE=Prostate;
RA   Aldridge T.C.;
RT   "Tissue specific responses to estrogen: an explanation based on
RT   differential activation of multiple estrogen receptors with different
RT   estrogen response elements.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 46-530 (ISOFORMS 1; 3 AND 4), AND FUNCTION (ISOFORMS
RP   1; 3 AND 4).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9492041; DOI=10.1210/endo.139.3.5840;
RA   Petersen D.N., Tkalcevic G.T., Koza-Taylor P.H., Turi T.G., Brown T.A.;
RT   "Identification of estrogen receptor beta2, a functional variant of
RT   estrogen receptor beta expressed in normal rat tissues.";
RL   Endocrinology 139:1082-1092(1998).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Price R., Handa R.J.;
RT   "A novel splice variant of estrogen receptor beta found in rat brain.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH UBE1C.
RX   PubMed=11818503; DOI=10.1210/mend.16.2.0778;
RA   Fan M., Long X., Bailey J.A., Reed C.A., Osborne E., Gize E.A., Kirk E.A.,
RA   Bigsby R.M., Nephew K.P.;
RT   "The activating enzyme of NEDD8 inhibits steroid receptor function.";
RL   Mol. Endocrinol. 16:315-330(2002).
RN   [7]
RP   INTERACTION WITH DNAAF4.
RX   PubMed=19423554; DOI=10.1093/hmg/ddp215;
RA   Massinen S., Tammimies K., Tapia-Paez I., Matsson H., Hokkanen M.E.,
RA   Soederberg O., Landegren U., Castren E., Gustafsson J.A., Treuter E.,
RA   Kere J.;
RT   "Functional interaction of DYX1C1 with estrogen receptors suggests
RT   involvement of hormonal pathways in dyslexia.";
RL   Hum. Mol. Genet. 18:2802-2812(2009).
RN   [8]
RP   INTERACTION WITH STUB1, AND TISSUE SPECIFICITY.
RX   PubMed=21808025; DOI=10.1073/pnas.1104391108;
RA   Zhang Q.G., Han D., Wang R.M., Dong Y., Yang F., Vadlamudi R.K.,
RA   Brann D.W.;
RT   "C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of
RT   hippocampal estrogen receptor-alpha and the critical period hypothesis of
RT   estrogen neuroprotection.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:E617-E624(2011).
CC   -!- FUNCTION: [Isoform 1]: Nuclear hormone receptor. Binds estrogens with
CC       an affinity similar to that of ESR1/ER-alpha, and activates expression
CC       of reporter genes containing estrogen response elements (ERE) in an
CC       estrogen-dependent manner. {ECO:0000250|UniProtKB:Q92731,
CC       ECO:0000269|PubMed:8650195, ECO:0000269|PubMed:9600083}.
CC   -!- FUNCTION: [Isoform 2]: Lacks ligand binding affinity and suppresses
CC       ESR1/ER-alpha and ESR2 isoform 1/ER-beta1 mediated transcriptional
CC       activation and may act as a dominant negative regulator of estrogen
CC       action. {ECO:0000269|PubMed:9600083}.
CC   -!- FUNCTION: [Isoform 3]: Unable to bind DNA and activate transcription
CC       due to the truncation of the DNA binding domain.
CC       {ECO:0000269|PubMed:9492041}.
CC   -!- FUNCTION: [Isoform 4]: Unable to bind DNA and activate transcription
CC       due to the truncation of the DNA binding domain.
CC       {ECO:0000269|PubMed:9492041}.
CC   -!- SUBUNIT: Binds DNA as a homodimer. Can form a heterodimer with ESR1.
CC       Interacts with NCOA1, NCOA3, NCOA5 and NCOA6 coactivators, leading to a
CC       strong increase of transcription of target genes. Interacts with UBE1C
CC       and AKAP13. Interacts with DNTTIP2 (By similarity). Interacts with
CC       CCDC62 in the presence of estradiol/E2; this interaction seems to
CC       enhance the transcription of target genes. Interacts with PRMT2.
CC       Interacts with CCAR2 (via N-terminus) in a ligand-independent manner
CC       (By similarity). Interacts with DNAAF4. Interacts with RBM39, in the
CC       presence of estradiol (E2) (By similarity). Interacts with STUB1/CHIP
CC       (PubMed:21808025). {ECO:0000250|UniProtKB:O08537,
CC       ECO:0000250|UniProtKB:Q92731, ECO:0000269|PubMed:11818503,
CC       ECO:0000269|PubMed:19423554, ECO:0000269|PubMed:21808025}.
CC   -!- INTERACTION:
CC       Q62986; P62989: Ubb; NbExp=2; IntAct=EBI-15938489, EBI-7038538;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92731}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Beta1;
CC         IsoId=Q62986-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta2;
CC         IsoId=Q62986-2; Sequence=VSP_003699;
CC       Name=3; Synonyms=Beta1-delta3;
CC         IsoId=Q62986-3; Sequence=VSP_003697;
CC       Name=4; Synonyms=Beta2-delta3;
CC         IsoId=Q62986-4; Sequence=VSP_003697, VSP_003699;
CC       Name=5; Synonyms=Beta1-delta4;
CC         IsoId=Q62986-5; Sequence=VSP_003698;
CC   -!- TISSUE SPECIFICITY: Expressed in the CA1 region of the hippocampus,
CC       expression decreases with age (at protein level) (PubMed:21808025).
CC       Expressed in prostate, ovary, lung, liver, kidney, fat, bone, brain,
CC       uterus and testis (PubMed:9600083). {ECO:0000269|PubMed:21808025,
CC       ECO:0000269|PubMed:9600083}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Phosphorylation at Ser-87 and Ser-105 recruits NCOA1.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA05631.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U57439; AAC52602.1; -; mRNA.
DR   EMBL; AB012721; BAA25431.1; -; mRNA.
DR   EMBL; AJ002602; CAA05631.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AJ002603; CAA05632.1; -; Genomic_DNA.
DR   EMBL; AF042058; AAB97424.1; -; mRNA.
DR   EMBL; AF042059; AAB97425.1; -; mRNA.
DR   EMBL; AF042060; AAB97426.1; -; mRNA.
DR   EMBL; AF042061; AAB97427.1; -; mRNA.
DR   EMBL; AF161187; AAD47637.1; -; mRNA.
DR   PIR; JW0046; JW0046.
DR   RefSeq; NP_036886.1; NM_012754.1.
DR   PDB; 1HJ1; X-ray; 2.30 A; A=255-509.
DR   PDB; 1QKN; X-ray; 2.25 A; A=255-509.
DR   PDB; 2J7X; X-ray; 2.10 A; A=255-509.
DR   PDB; 2J7Y; X-ray; 1.80 A; A=255-509.
DR   PDBsum; 1HJ1; -.
DR   PDBsum; 1QKN; -.
DR   PDBsum; 2J7X; -.
DR   PDBsum; 2J7Y; -.
DR   AlphaFoldDB; Q62986; -.
DR   SMR; Q62986; -.
DR   BioGRID; 247214; 6.
DR   DIP; DIP-60383N; -.
DR   IntAct; Q62986; 2.
DR   STRING; 10116.ENSRNOP00000043144; -.
DR   BindingDB; Q62986; -.
DR   ChEMBL; CHEMBL3021; -.
DR   DrugCentral; Q62986; -.
DR   GuidetoPHARMACOLOGY; 621; -.
DR   GlyCosmos; Q62986; 1 site, No reported glycans.
DR   GlyGen; Q62986; 1 site.
DR   PhosphoSitePlus; Q62986; -.
DR   PaxDb; 10116-ENSRNOP00000043144; -.
DR   GeneID; 25149; -.
DR   KEGG; rno:25149; -.
DR   UCSC; RGD:2582; rat. [Q62986-1]
DR   AGR; RGD:2582; -.
DR   CTD; 2100; -.
DR   RGD; 2582; Esr2.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; Q62986; -.
DR   OrthoDB; 5387678at2759; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8939211; ESR-mediated signaling.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   EvolutionaryTrace; Q62986; -.
DR   PRO; PR:Q62986; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:1903924; F:estradiol binding; IPI:RGD.
DR   GO; GO:0099130; F:estrogen binding; IPI:RGD.
DR   GO; GO:0034056; F:estrogen response element binding; IDA:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IPI:RGD.
DR   GO; GO:0042562; F:hormone binding; IDA:RGD.
DR   GO; GO:0030284; F:nuclear estrogen receptor activity; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:RGD.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; IDA:RGD.
DR   GO; GO:0097159; F:organic cyclic compound binding; IPI:RGD.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IPI:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0005496; F:steroid binding; IDA:UniProtKB.
DR   GO; GO:1990239; F:steroid hormone binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0021764; P:amygdala development; IEP:RGD.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001662; P:behavioral fear response; IDA:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; IBA:GO_Central.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:RGD.
DR   GO; GO:0071259; P:cellular response to magnetism; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0060743; P:epithelial cell maturation involved in prostate gland development; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0030520; P:estrogen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; IMP:RGD.
DR   GO; GO:0008585; P:female gonad development; IEP:RGD.
DR   GO; GO:0008628; P:hormone-mediated apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0021854; P:hypothalamus development; IEP:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048521; P:negative regulation of behavior; IDA:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:RGD.
DR   GO; GO:2000252; P:negative regulation of feeding behavior; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IDA:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IMP:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; IDA:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IEP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0045742; P:positive regulation of epidermal growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0030850; P:prostate gland development; IEP:RGD.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:1903925; P:response to bisphenol A; IEP:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0033595; P:response to genistein; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0044752; P:response to human chorionic gonadotropin; IEP:RGD.
DR   GO; GO:0017085; P:response to insecticide; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1902074; P:response to salt; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0060009; P:Sertoli cell development; IEP:RGD.
DR   GO; GO:0060011; P:Sertoli cell proliferation; IMP:RGD.
DR   GO; GO:0060065; P:uterus development; ISO:RGD.
DR   GO; GO:0060068; P:vagina development; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   CDD; cd07171; NR_DBD_ER; 1.
DR   CDD; cd06949; NR_LBD_ER; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR021064; ER-beta-like_N.
DR   InterPro; IPR028355; ER-beta/gamma.
DR   InterPro; IPR024178; Est_rcpt/est-rel_rcp.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050200; Nuclear_hormone_rcpt_NR3.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR48092:SF12; ESTROGEN RECEPTOR BETA; 1.
DR   PANTHER; PTHR48092; KNIRPS-RELATED PROTEIN-RELATED; 1.
DR   Pfam; PF12497; ERbeta_N; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PIRSF; PIRSF500102; ER-b; 1.
DR   PIRSF; PIRSF002527; ER-like_NR; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; DNA-binding; Glycoprotein;
KW   Lipid-binding; Metal-binding; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Steroid-binding; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..530
FT                   /note="Estrogen receptor beta"
FT                   /id="PRO_0000053646"
FT   DOMAIN          264..498
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        149..214
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         149..169
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         185..209
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..148
FT                   /note="Modulating"
FT   REGION          506..530
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         61
FT                   /note="Phosphoserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O08537"
FT   MOD_RES         87
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:O08537"
FT   MOD_RES         105
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:O08537"
FT   CARBOHYD        61
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         179..217
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003697"
FT   VAR_SEQ         219..318
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003698"
FT   VAR_SEQ         364
FT                   /note="R -> RSSEDPHWHVAQMKSAAPR (in isoform 2 and isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:9600083"
FT                   /id="VSP_003699"
FT   CONFLICT        72
FT                   /note="L -> Q (in Ref. 3 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="P -> A (in Ref. 3 and 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        165
FT                   /note="S -> P (in Ref. 3; CAA05631)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        505
FT                   /note="S -> P (in Ref. 3; CAA05631)"
FT                   /evidence="ECO:0000305"
FT   HELIX           265..274
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           291..315
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           319..321
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           324..347
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   STRAND          353..357
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   STRAND          360..363
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           364..369
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           373..390
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           394..405
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   TURN            406..409
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           421..443
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           448..481
FT                   /evidence="ECO:0007829|PDB:2J7Y"
FT   HELIX           489..496
FT                   /evidence="ECO:0007829|PDB:2J7Y"
SQ   SEQUENCE   530 AA;  59152 MW;  36F269D9FD773DA9 CRC64;
     MEIKNSPSSL SSPASYNCSQ SILPLEHGPI YIPSSYVDNR HEYSAMTFYS PAVMNYSVPG
     STSNLDGGPV RLSTSPNVLW PTSGHLSPLA THCQSSLLYA EPQKSPWCEA RSLEHTLPVN
     RETLKRKLSG SSCASPVTSP NAKRDAHFCP VCSDYASGYH YGVWSCEGCK AFFKRSIQGH
     NDYICPATNQ CTIDKNRRKS CQACRLRKCY EVGMVKCGSR RERCGYRIVR RQRSSSEQVH
     CLSKAKRNGG HAPRVKELLL STLSPEQLVL TLLEAEPPNV LVSRPSMPFT EASMMMSLTK
     LADKELVHMI GWAKKIPGFV ELSLLDQVRL LESCWMEVLM VGLMWRSIDH PGKLIFAPDL
     VLDRDEGKCV EGILEIFDML LATTSRFREL KLQHKEYLCV KAMILLNSSM YPLASANQEA
     ESSRKLTHLL NAVTDALVWV IAKSGISSQQ QSVRLANLLM LLSHVRHISN KGMEHLLSMK
     CKNVVPVYDL LLEMLNAHTL RGYKSSISGS ECSSTEDSKN KESSQNLQSQ
//
